Condition: Pelvic Organ Prolapse · Pelvic Organ Prolapse (POP) · Pelvic Organ Prolapse Vaginal Surgery · Sponsor: NICHD Pelvic Floor Disorders Network
The AccelERate study will evaluate the physical recovery of patients who have undergone Pelvic Organ Prolapse (POP) surgery. This will be evaluated via a self-reported recovery questionnaire completed daily. Participants will wear an accelerometer device on their non-dominant wrist and be given either routine or exercise-focused postoperative instructions. The primary outcome will be a comparison of the number of days needed to reach self-reported "mostly recovered" status between randomly assigned instruction groups.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Kaiser Permanente -- San Diego | San Diego, California, United States | Recruiting |
| University of California - San Diego | San Diego, California, United States | Recruiting |
| University of Chicago | Chicago, Illinois, United States | Recruiting |
| Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery | Durham, North Carolina, United States | Recruiting |
| University of Pennsylvania | Philadelphia, Pennsylvania, United States | Recruiting |
| Brown/ Women and Infants Hospital of Rhode Island, Division of Urogynecology and Reconstructive Pelvic Surgery | Providence, Rhode Island, United States | Recruiting |
| University of Texas Southwestern Medical Center | Dallas, Texas, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07218016